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Research Article
DHX15 regulates CMTR1-dependent gene expression and
cell proliferation
Francisco Inesta-Vaquera1, Viduth K Chaugule2, Alison Galloway1, Laurel Chandler3, Alejandro Rojas-Fernandez4,
Simone Weidlich5, Mark Peggie5, Victoria H Cowling1
CMTR1 contributes to mRNA cap formation by methylating the
ﬁrst transcribed nucleotide ribose at the O-2 position. mRNA cap
O-2 methylation has roles in mRNA stabilisation and translation,
and self-RNA tolerance in innate immunity. We report that CMTR1
is recruited to serine-5–phosphorylated RNA Pol II C-terminal
domain, early in transcription. We isolated CMTR1 in a complex
with DHX15, an RNA helicase functioning in splicing and ribosome
biogenesis, and characterised it as a regulator of CMTR1. When
DHX15 is bound, CMTR1 activity is repressed and the methyl-
transferase does not bind to RNA pol II. Conversely, CMTR1 ac-
tivates DHX15 helicase activity, which is likely to impact several
nuclear functions. In HCC1806 breast carcinoma cell line, the
DHX15–CMTR1 interaction controls ribosome loading of a subset
of mRNAs and regulates cell proliferation. The impact of the
CMTR1–DHX15 interaction is complex and will depend on the
relative expression of these enzymes and their interactors, and
the cellular dependency on different RNA processing pathways.
DOI 10.26508/lsa.201800092 | Received 16 May 2018 | Revised 4 June
2018 | Accepted 5 June 2018 | Published online 18 June 2018
Introduction
Formation of the mRNA cap initiates the maturation of RNA pol II
transcripts into translation-competent mRNA (Furuichi, 2015). The
mRNA cap protects transcripts from degradation and recruits protein
complexes involved in nuclear export, splicing, 39 processing, and
translation initiation (Topisirovic et al, 2011; Ramanathan et al, 2016).
mRNA cap formation initiates with the addition of an inverted
guanosine group, via a tri-phosphate bridge, to the ﬁrst transcribed
nucleotide of nascent RNA pol II transcripts. Subsequently, this
guanosine cap is methylated on the N-7 position to create the cap
0 structure, which binds efﬁciently to CBC, eIF4F, and other com-
plexes involved in RNA processing and translation initiation. The
initial transcribed nucleotides are further methylated at several
other positions in a species-speciﬁc manner. In mammals, the O-2
position of the riboses of the ﬁrst and second transcribed nucleo-
tides are sites of abundant methylation (Langberg & Moss, 1981).
A series of enzymes catalyse mRNA cap formation, which have
different conﬁgurations in different species (Shuman, 2002). In
mammals, RNGTT/capping enzyme catalyses guanosine cap ad-
dition and RNA guanine-7 methyltransferase (RNMT)-RNMT-acti-
vating miniprotein (RAM) catalyses guanosine cap N-7 methylation.
RNGTT/capping enzyme and RNMT-RAM are recruited to RNA pol II
at the initiation of transcription (Buratowski, 2009). CMTR1 and
CMTR2 methylate the O-2 position of ﬁrst and second transcribed
nucleotide riboses, respectively (Belanger et al, 2010; Werner et al, 2011;
Inesta-Vaquera & Cowling, 2017). CMTR1 (ISG95, FTSJD2, KIAA0082) was
ﬁrst identiﬁed as a human-interferon–regulated gene (Su et al, 2002;
Geiss et al, 2003; Guerra et al, 2003; Kato et al, 2003). It was rec-
ognised to have several functional domains including a methyl-
transferase domain (Haline-Vaz et al, 2008). Subsequently, CMTR1
was biochemically characterised as the O-2 ribose methyltransferase
of the ﬁrst transcribed nucleotide and the catalytic domain was
crystalized with S-adenosyl methionine (SAM) and a capped oli-
gonucleotide (Belanger et al, 2010; Smietanski et al, 2014).
CMTR1 and ﬁrst nucleotide O-2 methylation have functions in
gene expression and innate immunity. O-2 methylation is likely to
inﬂuence recruitment of cap-binding protein complexes and
promote ribosomal subunit binding (Muthukrishnan et al, 1976b).
Following fertilization of sea urchin eggs, N-7 and O-2 cap meth-
ylation is associated with translational up-regulation of a subset of
maternal transcripts (Caldwell & Emerson, 1985). During Xenopus
laevis oocyte maturation, ﬁrst nucleotide O-2 methylation sig-
niﬁcantly increases translation efﬁciency and is required for the
translation of maternal mRNA (Kuge & Richter, 1995; Kuge et al, 1998).
Recently, cap O-2 methylation was demonstrated to be critical for
preventing decapping exoribonuclease-mediated decapping, which
leads to RNA degradation (Picard-Jean et al, 2018). In mice, a sig-
niﬁcant proportion of the ﬁrst nucleotides were found to be O-2
methylated on the ribose, although the relative proportion of this
methylation varied between organs, indicating a regulated event
(Kruse et al, 2011).
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The composition of the 59 cap is also an important determinant of
self- (host) versus non–self-RNA during viral infection (Leung &
Amarasinghe, 2016). The absence of O-2 methylation in viral tran-
scripts results in enhanced sensitivity to the interferon-induced IFIT
proteins; ﬁrst nucleotide O-2 methylation distinguishes self from
non–self-RNA (Dafﬁs et al, 2010). CMTR1-dependent O-2 methylation
abrogates the activation of retinoic acid inducible gene I, a helicase
that initiates immune responses on interaction with uncapped or
aberrantly capped transcripts (Schuberth-Wagner et al, 2015).
Here, we report the ﬁrst regulator of CMTR1 function. We dem-
onstrate that CMTR1 and the DEAH (Asp-Glu-Ala-His)-box RNA heli-
case, DHX15, form a stable complex in cells and reciprocally inﬂuence
activity and action. DHX15 reduces CMTR1 methyltransferase activity.
CMTR1 activates DHX15 helicase activity and inﬂuences nuclear
localisation. Disruption of the CMTR1–DHX15 interaction leads to
increased ribosome loading of a subset of mRNAs involved in key
metabolic functions and impacts on cell proliferation.
Results
CMTR1 interacts directly with DHX15
To investigate the regulation and function of CMTR1, we identiﬁed
CMTR1-interacting proteins. HA-CMTR1 was immunoprecipitated
from HeLa cell extracts and resolved by SDS–PAGE, and co-puriﬁed
proteins were identiﬁed by mass spectrometry (Fig 1A). DHX15
(O43143), a 95-kD DEAH-box RNA helicase, was the only protein
identiﬁed with signiﬁcant mascot scores and coverage in HA-CMTR1
immunoprecipitates (IP) (Fig S1) (Imamura et al, 1997). Conversely,
CMTR1 was identiﬁed in HA-DHX15 IPs using mass spectrometry
(Figs 1B and S1). To verify their interaction, GFP-CMTR1 and FLAG-
DHX15 were expressed in HeLa cells and co-immunoprecipitated
from cell extracts (Fig 1C). To investigate endogenous CMTR1, an
antibody was raised against recombinant human CMTR1, which
detected CMTR1 in HeLa cell extracts using Western blot and im-
munoprecipitation (IP) (Fig S2A and B). The interaction of endog-
enous CMTR1 and DHX15 was conﬁrmed using IP in HeLa, HCC1809,
U2OS, and HEK293 cell extracts (Fig 1D). In CMTR1 null HeLa cells, the
anti-CMTR1 antibody was unable to purify DHX15, discounting non-
speciﬁc interactions of DHX15 with resin or antibody (Fig 1E).
Demonstrating the speciﬁcity of the CMTR1–DHX15 interaction,
DHX16, another DEAH RNA helicase, was not detected in CMTR1 IPs,
and RNMT, another cap methyltransferase, was not detected in
DHX15 IPs (Fig S2C and D). Furthermore, the CMTR1–DHX15 in-
teraction was sustained on RNaseA treatment and therefore is not
maintained by an RNA connector (Fig 1F). In HeLa cells, DHX15
and CMTR1 are expressed at equivalent molar ratios (Nagaraj et al,
2011). Equimolar recombinant human CMTR1 and His6-DHX15 co-
immunoprecipitated, conﬁrming their direct interaction (Figs 1G
and S2E). Neither CMTR1 or DHX15 homodimerise (Fig S2F and G).
To gain insight into CMTR1 and DHX15 complexes in HeLa cells, gel
ﬁltration analysis was performed. Used as markers, recombinant
CMTR1 and His6-DHX15 monomers migrated as expected for ~100 kD
monomers (Fig 1H, lower panels, 14.5 ml). HeLa extracts were treated
with RNases I and A before gel ﬁltration to prevent protein–protein
interaction via a RNA linker (Figs 1H, upper panels, and S2H). Cellular
CMTR1 and DHX15 co-eluted after the 158 kD marker consistent with
DHX15–CMTR1 heterodimers. As described above, no other inter-
acting proteins were identiﬁed in mass spectrometry analysis of
CMTR1 IPs (Figs 1A and S1). Conversely, DHX15, was also observed in
larger, CMTR1-independent complexes by gel ﬁltration (Fig 1H,
11.5 ml). Mass spectrometry analysis of DHX15 IPs identiﬁed a series
of other proteins, including some with a G-patch domain. Novel and
all previously reported DHX15 interactors were identiﬁed, including
those involved in ribosomal biogenesis and splicing (Figs 1B and
S3). This result reﬂects the well-documented function of DHX15 and
its homologues in these processes (Robert-Paganin et al, 2015;
Memet et al, 2017). Although these other DHX15 complexes are
biologically interesting, for the remainder of this study we focus on
the relationship between DHX15 and CMTR1.
CMTR1 G-patch domain interacts with the DHX15 oligonucleotide/
oligosaccharide binding (OB)–fold
CMTR1 is an 835 residue protein containing an NLS (residues 2–19),
a G-patch domain (residues 85–133), an RrmJ-type SAM-dependent
O-2 methyltransferase domain (RFM, residues 170–550), a guany-
lyltransferase-like domain (GT-like, residues 560–729), and a WW
domain (755–790) (Fig 2A) (Aravind & Koonin, 1999; Haline-Vaz et al,
2008; Belanger et al, 2010; Smietanski et al, 2014). To map the
interacting regions of CMTR1 and DHX15, HeLa cells were transfected
with GFP-CMTR1 wild-type (WT) or mutants ΔN (25–835), ΔG
(143–835), 1–143, and Gp (85–143), or GFP alone (Fig 2A). Endogenous
DHX15 co-immunoprecipitated with GFP-CMTR1 WT and mutants
except GFP-ΔG, the G-patch deletion mutant (Fig 2B). Furthermore,
DHX15 co-immunoprecipitated with GFP-Gp, the G-patch domain of
CMTR1, indicating that this domain mediates the interaction.
DHX15 is a prototypic member of the DEAH family of RNA heli-
cases (Jankowsky, 2011). It contains an N-terminal domain of un-
known function (N-term, residues 1–146), two Rec-A tandem repeats
(Rec A1–A2, residues 147–518), a WH domain (residues 519–572),
a ratchet domain (residues 572–671), and an OB-fold (residues
671–795) (Fig 2C). The OB-fold is the predominant site of interaction
with RNA and proteins, although the Rec-A domains can also es-
tablish functional interactions with RNA and protein (Lebaron et al,
2009). Other G-patch–containing proteins have been demonstrated
to interact with DHX15 via the OB-fold (Fig S3) (Lin et al, 2009; Niu
et al, 2012; Chen et al, 2014; Memet et al, 2017). To determine whether
the DHX15 OB-fold is required for CMTR1 binding, HA-DHX15 WT or
C-terminal deletion mutant (ΔC, 1–635) were expressed in HeLa
cells. Endogenous CMTR1 immunoprecipitated with HA-DHX15 WT
but not ΔC (Fig 2D).
G-patch domains have the consensus sequence,
hhxxxGaxxGxGhGxxxxG; “G” is glycine, “h” is a bulky, hydrophobic
residue (I, L, V, M), “a” is an aromatic residue (F, Y, W), and “x” is any
residue (Aravind & Koonin, 1999). The CMTR1 G-patch has this
consensus and in addition leucines at residues 94, 106, and 128which
are conserved in the G-patch domains of the established DHX15
interactors, PINX1, NKRF, GPATCH2, and RBM5 (Fig 2E) (Lin et al, 2009;
Niu et al, 2012; Chen et al, 2014; Memet et al, 2017). Because these
conserved leucines in other DHX15-binding proteins are required for
the interaction, the impact of mutating CMTR1 L94, L106, and L128 to
alanine was investigated using the 2L/A mutant (L94A and L106A),
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Figure 1. DHX15 interacts with CMTR1.
(A) HA-CMTR1 was doxycyline-induced (Dox) in a HeLa cell line. Anti-HA antibody immunoprecipitation (IP) was performed on cell extracts. IPs were resolved by SDS–PAGE
and Coomassie Blue-stained. HA-CMTR1, DHX15, antibody heavy chain (HC), and light chain (LC) are indicated. (B) pcDNA5 HA-DHX15 WT, 1-635 (ΔC), and vector control (V)
were transfected into HeLa cells. Anti-HA IP was performed and analysed as in (A). (C) pcDNA5 GFP-CMTR1 and FLAG-DHX15 were expressed in HeLa cells. IPs were
performed on cell extracts using anti-GFP and FLAG antibodies. (D) Endogenous CMTR1 (left panels) or DHX15 (right panels) was immunoprecipitated from extracts of the
cell lines indicated; Western blot analysis. Sheep IgG was used for IP control. (E) In HeLa cells, transfection of guide RNAs and Cas9 resulted in a CMTR1 null cell line.
Endogenous CMTR1 IP was performed on extracts of HeLa cells (WT) or CMTR1 null HeLa cells (null). (F) CMTR1 IPs from HeLa cells were untreated or incubated with RNAase
A prior to analysis. (G) 100 ng recombinant CMTR1 and 100 ng His6-DHX15 were mixed and subjected to IP with indicated antibodies. *denotes non-speciﬁc band. (H) HeLa
cell extracts were treated with RNaseI and RNaseA. Extracts, recombinant CMTR1, or recombinant His6-DHX15 were resolved on a Superdex s200 10/30 column. Fractions
were analysed by Western blot. Elution of standards indicated.
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Figure 2. CMTR1 G-patch domain binds to DHX15 OB-fold domain.
(A) Diagram of CMTR1 domains and mutants made. (B) HeLa cells were transfected with pcDNA5 (V), or with pcDNA5 GFP, GFP-CMTR1 WT, and mutants. Anti-GFP-antibody
IPs (GFP-IP) were performed and analysed by Western blot. Inputs were also analysed (in). (C) Diagram of DHX15 domains and mutants made. (D) HeLa cells were
transfected with pcDNA5 (V), pcDNA5 HA-DHX15, and mutants. Anti-HA antibody IPs (HA-IP) were performed and analysed by Western blot. (E) Alignment of G-patch
domains in DHX15 interactors generated by Clustal Omega Alignment tool. Conserved leucines in CMTR1 in red. Residues: “.,” weakly similar; “:,” strongly similar; “*,”
conserved. (F) HeLa cells were transfected with pcDNA5 HA-CMTR1 WT and mutants. HA-IPs were performed and analysed by Western blot.
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Figure 3. CMTR1 methyltransferase activity is repressed by DHX15.
(A) GpppG-capped RNA was incubated with 3 nM CMTR1 or 3 nM CMTR1 and 3 nM His6-DHX15 for the time indicated. Caps throughout the ﬁgure are 32P-labelled on
α-phosphate. Generated GpppGm (ﬁrst transcribed nucleotide ribose 0–2 methylated) resolved by thin-layer chromatography and detected by autoradiography. (B)
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and the 3L/A mutant (L94A, L106A, and L128A) (Fig 2E). The 2L/A
mutation was sufﬁcient to abrogate the interaction of CMTR1 with
DHX15, conﬁrming that CMTR1 interacts with DHX15 through the
G-patch domain (Fig 2F).
DHX15 inhibits CMTR1 methyltransferase activity
To investigate the biochemical impact of the CMTR1–DHX15 in-
teraction, we ﬁrst analysed CMTR1 methyltransferase activity. A 32P-
labelled, guanosine-capped transcript (GpppG) was incubated with
recombinant CMTR1 and a methyl donor, SAM (Fig 3A). First tran-
scribed nucleotide O-2 methylation (GpppG to GpppGm conversion)
was observed by resolution on thin-layer chromatography (Belanger
et al, 2010). Incubation of recombinant CMTR1 with equimolar
recombinant His6-DHX15 resulted in an approximately 50% reduction
in O-2 methylation (Fig 3A and B). Similarly, His6-DHX15 signiﬁcantly
inhibited O-2 methylation of a 7-methylguanosine-capped tran-
script (m7GpppG to m7GpppGm conversion) (Figs 3C and D, and S4A
and B). His6-DHX15 inhibited CMTR1-dependent methylation in
a dose-dependent manner (Fig 3C and D). The impact of DHX15 on
CMTR1-methyltransferase activity was also observed in cells. Trans-
fection of HeLa cells with a titration of pCDNA5 HA-CMTR1 resulted
in dose-dependent O-2 methyltransferase activity in cell extracts
(Fig 3E). Transfection with pCDNA5 GFP-DHX15 inhibited methyl-
transferase activity in cell extracts. As controls, ATP did not alter
DHX15-dependent repression of CMTR1, and BSA and recombinant
protein storage buffer did not affect CMTR1-dependent methylation
(Fig S4C–E).
To investigate whether the interaction of DHX15 and CMTR1 is
required for inhibition of methyltransferase activity, CMTR1ΔG
mutant, which does not interact with DHX15, was utilised (Figs 2A
and B, and 3F). Recombinant CMTR1ΔG had slightly reduced activity
compared with WT (Fig S4F); however, its methyltransferase activity
was not inhibited by DHX15 (Fig 3G). This indicates that direct
binding of DHX15 is required for the inhibition of CMTR1 methyl-
transferase activity. Because DHX15 is a helicase, we determined the
requirement for its catalytic activity to inhibit CMTR1 methyl-
transferase activity. Incubation of recombinant CMTR1 with equi-
molar recombinant His6-DHX15 WT or E261Q (Memet et al, 2017),
a catalytically inactive mutant, resulted in an equivalent reduction
in methyltransferase activity (Fig 3H). Therefore, inhibition of CMTR1
activity is a non-catalytic function of DHX15.
To gain insight into the mechanism of CMTR1 inhibition by DHX15,
we investigated the impact on RNA binding. Unfortunately, we were
unable to purify CMTR1 bound to RNA in cells using cross-linking
methodologies which however detected RNMT–RNA interactions
(Varshney et al, 2018). This may reﬂect the dynamic nature of
CMTR1–RNA interactions in cells. However, recombinant CMTR1 could
be detected interacting with GpppG-RNA, visualised as mobility shifts
on a non-denaturing acrylamide gel (Fig 3I). Two major mobility
CMTR1-RNA shifts were observed. Because the recombinant CMTR1
used in these studies was highly puriﬁed (Fig S2E), two mobility shifts
is likely to indicate conformational isomers in CMTR1-RNA complexes.
An interaction between His6-DHX15 alone and GpppG-RNA was not
observed. In the presence of increasing amounts of DHX15, the CMTR1
GpppG-RNA complex was not reduced and further bands were ob-
served, indicating GpppG-RNA-CMTR1-DHX15 complexes. Although
in vitro, these RNA-protein interaction studies indicate that DHX15
does not reduce the afﬁnity of CMTR1 for the GpppG-RNA substrate.
CMTR1 increases DHX15 helicase activity
To determine the impact of the CMTR1–DHX15 interaction, we also
investigated whether CMTR1 inﬂuences DHX15 ATPase and helicase
activity (Fig 4). Recombinant His6-DHX15 was incubated with α32P-
ATP and hydrolysis visualised by the detection of α32P-ADP (Fig 4A
and B). As established, addition of RNA signiﬁcantly increased ATP
hydrolysis (Fig 4A and B, and S5) (Walbott et al, 2010; Memet et al,
2017). Previously characterised G-patch–containing interactors of
Prp43 or DHX15 have variable impact on ATPase activity (Tanaka
et al, 2007; Lebaron et al, 2009; Niu et al, 2012). To determine whether
CMTR1 inﬂuences DHX15-dependent ATP hydrolysis, a titration of
recombinant CMTR1 was included in the ATPase assay. CMTR1 did
not activate or repress basal DHX15-dependent ATP hydrolysis (Fig
4C and D). Furthermore, CMTR1 did not activate or repress RNA-
stimulated DHX15-dependent ATP hydrolysis (Fig 4E). Addition of
SAM had no impact on DHX15-dependent ATP hydrolysis, including
in the presence of CMTR1 or RNA (Fig 4F).
Because interactors of Prp43, the yeast DHX15 homologue, can
regulate helicase activity independently of ATPase activity, we in-
vestigated whether CMTR1 could regulate DHX15 helicase activity
(Tanaka et al, 2007). A 32P-DNA-RNA duplex was incubated with 1,000
nM His6-DHX15 and helicase activity was conﬁrmed by the loss of
the duplex (Fig 4G, compare lanes 2 and 7). When 100 nMHis6-DHX15
was used in this assay, reduced helicase activity was observed, as
expected (lane 3). Addition of CMTR1 increased helicase activity in
a dose-dependent manner (Fig 4G, lanes 4–6, and H). CMTR1 alone
had no helicase activity (Fig 4G, lane 8).
CMTR1 interaction with DHX15 and RNA pol II CTD are mutually
exclusive
CMTR1 interacts with RNA pol II, which may permit efﬁcient co-
transcriptional ﬁrst nucleotide O-2 methylation (Haline-Vaz et al,
Percentage conversion of GpppG to GpppGm (% GpppG O-2 meth) is plotted. Average and standard deviation for three independent experiments are plotted here
and throughout the ﬁgure. (C) m7GpppG-capped RNA was incubated with 0.5 nM CMTR1 and indicated nM His6-DHX15 for 30 min. Generated of m7GpppGm detected.
(D) Average percentage of m7GpppG O-2 meth and standard deviation are plotted. (E) HeLa cells were transfected with 5 μg pcDNA GFP or GFP-DHX15 and 0, 0.4, or 2 μg
pcDNA5 HA-CMTR1, as indicated. 1 d after transfection, cells were harvested and 5 μg cell extract was used in O-2 methyltransferase assay. Percentage of GpppG O-2 meth
and standard deviation of duplicates are reported. (F) 100 ng recombinant GST-CMTR1ΔG and 100 ng His6-DHX15 were mixed and subjected to IP with indicated antibodies;
Western blot analysis. *denotes non-speciﬁc band. (G) GpppG-capped RNA was incubated with 5 nM GST-CMTR1ΔG or 5 nM GST-CMTR1ΔG and 5 nM His6-DHX15.
Average percentage of GpppG O-2 meth and standard deviation are plotted. (H) GpppG-capped RNA was incubated with 3 nM CMTR1 and 3 nM His6-DHX15 WT or E261Q.
Average percentage of GpppG O-2 meth and standard deviation are plotted. Where relevant, t test was performed. *P-value < 0.05; **P-value < 0.01; ***P-value < 0.005.
(I) 55 nt 32P GpppG-RNA incubated with 100 ng CMTR1 and indicated ng His6-DHX15. Complexes were resolved in a 4%–20% tris-borate-EDTA buffer non-denaturing
acrylamide gel and detected using a phosphorimager (GE healthcare Life Sciences). Migration of 32P GpppG-RNA probe and complexes are indicated.
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2008). We investigated the impact of DHX15 on CMTR1 recruitment to
RNA pol II. The interaction of recombinant CMTR1 and DHX15 with
a biotinylated peptide consisting of three RNA pol II C-terminal
domain heptad repeats, (YSPTSPS)3, unphosphorylated (CTD), or
phosphorylated on serine-5 (pCTD), was investigated (Fig 5A–C). As
a control, RNGTT was demonstrated to interact with pCTD but not
CTD (Fig S6A) (Ho & Shuman, 1999). The CMTR1 monomer bound to
pCTD but not to CTD (Fig 5A), whereas the His6-DHX15 monomer did
not bind to either peptide (Fig 5B). To investigate whether CMTR1
can recruit DHX15 to pCTD, the recombinant proteins were mixed
before peptide pulldown. Although CMTR1 and DHX15 interact
in vitro (Fig 1G), CMTR1 was recruited to pCTD, whereas DHX15 was
not, revealing that DHX15–CMTR1 complexes are not recruited to
pCTD (Fig 5C).
The interaction of CMTR1 and DHX15 with RNA pol II was in-
vestigated in cells. In HeLa cell extracts, endogenous CMTR1 co-
immunoprecipitated with RNA pol II phospho-Ser5-CTD (pSer5-CTD),
but not phospho-Ser2-CTD (pSer2-CTD) or unphosphorylated RNA
pol II (Fig 5D). The interaction of CMTR1 and pSer5-CTD was RNase
A–insensitive and, therefore, RNA-independent (Fig S6B). To map
the interaction of CMTR1 with RNA pol II, GFP-CMTR1 WT; 1–143, ΔG,
and ΔC (1–173); and HA-CMTR1, 2L/A, and ΔC were expressed in HeLa
cells and immunoprecipitated via their tags, and pSer5-CTD binding
was determined (Fig 5E and F). GFP-CMTR1 and HA-CMTR1 interacted
with pSer5-CTD, whereas GFP-CMTR1ΔC and HA-CMTR1ΔC did not,
indicating that the WW domain mediates the interaction with RNA
pol II (Fig 5E and F). GFP-CMTR1ΔG and HA-CMTR1 2L/A (both de-
fective for DHX15 binding) interacted with pSer5-CTD, conﬁrming
that in cells DHX15 is not required for CMTR1 recruitment to RNA pol
II (Fig 5E and F).
Although DHX15 is not required for CMTR1 recruitment to pSer5-
CTD (Fig 5A, C, E, and F), it was important to determine whether
DHX15 binds to RNA pol II in cells, either independently of CMTR1 or
in a complex with it. HA-DHX15 was expressed in HeLa cells and
immunoprecipitated via the HA tag (Fig 5G). As expected, HA-DHX15
bound to CMTR1 but not to pSer5-CTD or unphosphorylated RNA
pol II. This conﬁrms that in cells, as in vitro, DHX15 does not ap-
preciably interact with RNA pol II (Fig 5B, C, and G) and, furthermore,
that the CMTR1-DHX15 complex does not interact with RNA pol II
(Fig 5C and G).
CMTR1 inﬂuences DHX15 localisation
Following biochemical analysis of the CMTR1-DHX15 interaction, we
investigated whether DHX15 inﬂuences CMTR1 localisation. We
conﬁrmed that GFP-CMTR1 and endogenous CMTR1 are predomi-
nantly nuclear in HeLa cells (Fig 6A–C) (Haline-Vaz et al, 2008). A
potential CMTR1 nuclear localisation signal was identiﬁed, 14KKQKK
(Lange et al, 2007). Mutation of CMTR1 14KKQKK to 14EEQEE (4K/E) or
removal of the ﬁrst 25 residues (ΔN) resulted in partial cytoplasmic
localisation, conﬁrming that 14KKQKK contributes to nuclear
localisation. To determine the impact of DHX15 on CMTR1 local-
isation, the localisation of GFP-CMTR1 3L/A (does not bind DHX15)
was investigated. GFP-CMTR1 3L/A was predominantly nuclear,
indicating that DHX15 does not inﬂuence CMTR1 localisation (Fig 6A).
Furthermore, suppression of DHX15 expression did not alter CMTR1
nuclear localisation (Fig 6B).
Because we had observed that CMTR1 stimulates DHX15 helicase
activity in vitro, we investigated whether it also inﬂuences DHX15
localisation in cells. Prp43, the yeast homologue of DHX15, occupies
several cellular locations to execute different biological functions
(Heininger et al, 2016). The different Prp43 locations are achieved by
the competition of G-patch proteins, which recruit the helicase to
different parts of the cell. In HeLa cells, DHX15 exhibited a diffuse
nuclear localisation (Fig 6B and C). However, in approximately
a third of cells, DHX15 also exhibited speckled nuclear foci,
a common feature of splicing factors (Tannukit et al, 2009). DHX15
foci partially co-localized with the splicing factor SC35 (Pawellek
et al, 2014) (Fig S7A). The number of cells exhibiting DHX15 nuclear
foci increased when CMTR1 was knocked down (Figs 6C and S7B) or
in the cmtr1 null HeLa cell line (Fig S7C and D). The potential impact
of CMTR1 on DHX15 localisation is explored in the Discussion
section.
DHX15 represses CMTR1-dependent translation
We had observed that DHX15 inhibits CMTR1-dependent O-2
methylation (Fig 3), CMTR1 activates DHX15-dependent helicase
activity (Fig 4), and DHX15–CMTR1 complexes are not present on RNA
pol II (Fig 5). The net outcome of the DHX15 and CMTR1 relationships
is therefore complex and will depend on many factors (see the
Discussion section). Here, we focussed our investigation on the
impact of DHX15 on CMTR1 function using the CMTR1 2L/A mutant,
which does not bind to DHX15 (Fig 2F), but is recruited to RNA pol II
(Fig 5F). Because ﬁrst nucleotide ribose O-2 methylation is asso-
ciated with enhanced translation, the impact of the DHX15–CMTR1
interaction on this process was investigated (Kuge et al, 1998).
Initially we attempted to express CMTR1 WT and 2L/A mutant in
CMTR1 null HeLa cells (Fig 1E). CMTR1 WT and 2L/A were expressed
equivalently in the ﬁrst 3 d after initial transduction. However, after
selection, cells expressing the WT protein survived, whereas cells
expressing the 2L/A mutant did not, indicating some growth dis-
advantage of the mutant. Therefore, CMTR1 2L/A was expressed in
the presence of endogenous CMTR1. HCC1806 cells, a mammary
epithelial tumour cell line, were selected for these experiments
because we had previously established that these cells are highly
sensitive to changes in the CMTR1 expression level. Cells were
transfected with pcDNA5 HA-CMTR1 WT, 2L/A, or vector control and
polysome proﬁling analysis was performed in which free ribosomes
and ribosomal subunits are separated from translating ribosomes
in a sucrose gradient (Fig 7A). Expression of HA-CMTR1 WT and 2/LA
were equivalent (Fig 7B). Although expression of CMTR1 WT and 2L/A
had a mild impact on the polysome proﬁles, in multiple experi-
ments, the ratios between polysomes and monosomes were not
signiﬁcantly different, indicating that the CMTR1–DHX15 interaction
was not having a broad impact on translational control (Fig 7C). To
investigate gene-speciﬁc effects, RNA sequencing (RNAseq) anal-
ysis was used to quantify total cellular transcripts and the tran-
scripts associated with most dense ribosome binding (Fig 7A,
shaded area, and Tables S1 and S2). Out of the 12,238 gene tran-
scripts that passed quality thresholds, none exhibited a signiﬁcant
difference in expression level in cells expressing CMTR1 WT and 2L/A
(Table S1 and Fig 7D). This indicates that in HCC1806 cells, the
CMTR1–DHX15 interaction is unlikely to have a signiﬁcant impact on
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Figure 4. CMTR1 methyltransferase stimulates DHX15 helicase activity.
(A) 100 nM His6-DHX15 was incubated with α32P-ATP in the absence or presence of 1 μg HeLa cell RNA for the time indicated. The ADP generated was resolved by TLC and
detected by phosphoimager throughout the ﬁgure unless indicated. (B) Average percentage of ATP hydrolysis and standard deviation are plotted for two experiments.
(C) 100 nM His6-DHX15 was incubated with α32P-ATP and 1 μg RNA or nM CMTR1 indicated for 30 min. ATP hydrolysis was detected. (D) Average percentage ATP hydrolysis
and standard deviation are plotted for three independent experiments. t test was performed relative to DHX15 alone. ***P-value < 0.005. (E) 100 nM His6-DHX15
alone or 100 nM His6-DHX15, 1 μg HeLa RNA, and indicated concentration of CMTR1 were incubated with α32P-ATP for 30 min. Percentage of ATP hydrolysis is plotted over
time. (F) 100 nM DHX15 was incubated with 10 μM SAM, 1 μg HeLa RNA, and 100 nM CMTR1 as indicated for 30 min. Percentage of ATP hydrolysis is plotted. (G) RNA-32P-DNA
duplex was incubated with with1mM ATP and indicated nM His6-DHX15 and CMTR1. After 30 min, samples were resolved by native PAGE and visualized using
a phosphorimager. “Unwound” indicates single stranded 32P-DNA oligonucleotide. ΔT is the 95°C denatured substrate. (H) Average percentages of unwound substrate and
standard deviations are presented for three independent experiments.
DHX15 and CMTR1 co-regulation Inesta-Vaquera et al. https://doi.org/10.26508/lsa.201800092 vol 1 | no 3 | e201800092 8 of 18
transcription or RNA stability. However, 59 gene transcripts were
signiﬁcantly enriched in polysomes in cells expressing CMTR1 2L/A
compared with WT. This indicates that the DHX15–CMTR1 interaction
restricts the translation of a subset of mRNAs (Fig 7E and F and
Table S2). Conversely, no genes were signiﬁcantly depleted from
polysomes in cells expressing CMTR1 2L/A compared with WT.
The genes that exhibited enhanced translation in cells
expressing CMTR1 2L/A were enriched for gene ontology terms
associated with important metabolic functions and cell cycle
processes (Table S3). Notably, there was enrichment for gene
encoding factors involved with the cell cycle and DNA damage
responses including ATR, UBR4, UBR2, CENPE, PRKDC, and BIRC6;
factors involved in RNA processing including GCN1, TPR, RANBP2,
and NUP205; metabolic enzymes including FASN, EPRS, and CAD;
and focal adhesion-associated molecules HSPG2, FLNB, MYH9, FAT1,
IGF2R, and CLTC. The polysome loading of selected genes was con-
ﬁrmed by RT–PCR and enhanced protein expression conﬁrmed by
Western blot (Fig 7G and H). This analysis indicates that DHX15
Figure 5. CMTR1 interaction with DHX15 and RNA pol II CTD are mutually exclusive.
(A) Recombinant CMTR1, (B) recombinant His6-DHX15, (C) pre-mixed CMTR1, and His6-DHX15, were incubated with biointinylated peptides of three RNA pol II CTD
heptad repeats, either unphosphorylated (CTD) or phosphorylated on S5 (pCTD). Peptides were enriched on streptavidin beads and associated proteins analysed by
Western blot. (D) CMTR1 was immunoprecipitated from extracts of HeLa cells (WT) or HeLa CMTR1 null cells. Western blot analysis was performed. (E) pcDNA5 GFP-CMTR1
or indicated mutants were expressed in HeLa cells. IPs were performed with anti-GFP antibodies and analysed by Western blot. (F) pcDNA 5 HA-CMTR1 or indicated
mutants were expressed in HeLa cells. IPs were performed with anti-HA antibodies and analysed by Western blot. (G) pcDNA5 HA-CMTR1 and mutants were expressed
in HeLa cells. IPs were performed with anti-HA antibodies and analysed by Western blot. Aff, afﬁnity puriﬁed fraction; In, input; FT, ﬂow through.
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represses the positive effect of CMTR1 on cell growth and
proliferation.
The interaction of DHX15 and CMTR1 inhibits proliferation
The impact of CMTR1 expression on cell proliferation was in-
vestigated in HCC1806 cells and another mammary epithelial tu-
mour line, MCF7. Transfection of two independent CMTR1 siRNAs
resulted in the suppression of CMTR1 expression and a reduction in
cell proliferation (Fig 8A–C). Given that expression of CMTR1 2L/A
resulted in increased polysome loading of genes involved in
metabolism and cell cycle, we investigated its impact on cell pro-
liferation. When HA-CMTR1 was transiently expressed in sparsely
plated HCC1806 cells, a signiﬁcant increase in cell number was
observed after 24 h (Fig 8D). Transient expression of HA-CMTR1 2L/A
resulted in a further increase in cell number, supporting the hy-
pothesis that DHX15 suppresses the translation of a subset of pro-
growth genes. To investigate if the increased expression of these
genes may contribute to the enhanced proliferation observed
on expression of CMTR1 2L/A, two genes with increased polysome
Figure 6. DHX15 localisation is inﬂuenced by CMTR1.
(A) Representative ﬂuorescence images of GFP-CMTR1
WT or mutants expressed in HeLa cells. Cells were
DAPI-stained to visualise DNA. (B) HeLa cells were
transfected with DHX15 siRNA or non-targeting control.
Representative immunoﬂuorescence (IF) images of
endogenous CMTR1 and DHX15 presented. Images
show CMTR1 (red), DHX15 (green), and DAPI (blue). (C)
As in (B), except cells were transfected with CMTR1
siRNA or control. Yellow asterisks indicate cells with
DHX15 accumulation in foci. 4.5× magniﬁed areas
marked. Data representative of three independent
experiments. Bar indicates 20 μm.
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loading in CMTR1 2L/A cells, CAD and GCN1, were suppressed by
siRNA transfection (Fig 8E). Suppression of CAD and GCN1 resulted
in reduced proliferation of HCC1806 cells, supporting the hypoth-
esis that DHX15 controls CMTR1-dependent translation of a subset
of pro-growth genes.
Discussion
Higher eukaryotes carry unique mRNA cap modiﬁcations, including
ﬁrst transcribed nucleotide ribose O-2 methylation, which is as-
sociated with translation and self-RNA identiﬁcation (Kuge et al,
1998; Schuberth-Wagner et al, 2015; Leung & Amarasinghe, 2016). We
investigated cellular regulation of CMTR1, the ﬁrst nucleotide ribose
O-2 methyltransferase (Belanger et al, 2010). CMTR1 was isolated
frommammalian cells in a complex with DHX15 (human orthologue
of yeast Prp43), a DEAH-box helicase involved in RNA processing,
splicing, and ribosome biogenesis (Koodathingal & Staley, 2013;
Robert-Paganin et al, 2015). DHX15 has an OB-fold domain through
which it binds to the G-patch domain in a series of proteins, fa-
cilitating contribution to several nuclear functions (Niu et al, 2012;
Chen et al, 2014; Robert-Paganin et al, 2015; Memet et al, 2017;
Tauchert et al, 2017). Previous studies indicated that CMTR1 and
DHX15 participate in the same mRNA processing events (Yoshimoto
Figure 8. The DHX15–CMTR1 interaction inhibits cell proliferation.
(A)MCF7 cells were transfected with two independent CMTR1 siRNAs or non-targeting control. Cell extracts were analysed by Western blot. (B)MCF7, (C) HCC1806 cells were
transfected with two independent CMTR1 siRNAs or non-targeting control. Cells were counted every day. HCC1806 were transfected with (D) pcDNA5 CMTR1 WT or 2L/A or
vector control. After 48 h cells were counted. Average and standard deviation presented for 3–5 independent wells. (E) As in (D) except cells were also transfected with and
50 nM CAD, GCN1 or non-targeting control siRNA. t test was performed. *P-value < 0.05; **P-value < 0.01; ***P-value < 0.005.
Figure 7. The DHX15–CMTR1 interaction inhibits translation of a subset of genes.
(A) Extracts from HCC1806 cells transfected with pCDNA5 HA-CMTR1, 2L/A, or vector control (V) were centrifuged through 10%–50% sucrose gradients. 259 nm absorbance
was determined across the gradient in four independent experiments. Representative experiment presented. The fraction of the gradients analysed by RNAseq is
indicated by shaded boxes. The identities of the peaks in the polysome proﬁles is indicated. (B) Cell extracts were analysed by Western blot. (C) Average and standard
deviation of ratio of polysome to mononosome absorbance for four independent experiments. RNAseq analysis was used to determine uniquely aligned reads per gene
(transcript isoforms collapsed) in RNA and polysome samples from HCC1806 cells expressing HA-CMTR1 WT and 2L/A (n = 2). (D) Scatter plot of log2 transformed total
counts permillion (log2CPM) in total RNA. (E) Scatter plot of log2-fold change (FC) in 2L/A/WT for total RNA and polysomal RNA. Signiﬁcantly regulated genes determined by
a negative binomial rest in EdgeR in red. (F) Scatter plot of log2-transformed counts per million (log2CPM) in polysomal RNA. (G) Polysomal mRNA levels quantiﬁed by
RT–PCR. Average and standard deviation for three independent experiments. t test was performed ***P-value < 0.005. (H)Western blot analysis of proteins in HCC1806 cells
expressing pCDNA5 HA-CMTR1, 2L/A, or vector control (V). Charts represented average protein signal in Western blots and standard deviation for three independent
experiments. Quantitation performed in ImageJ software.
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et al, 2014; Gebhardt et al, 2015). Here, we demonstrate that the
direct interaction of CMTR1 and DHX15 regulates the catalytic ac-
tivity of both enzymes, which impacts gene expression and cell
proliferation.
DHX15 constrains CMTR1 function
mRNA cap formation initiates early during transcription, when
RNGTT (RNA triphosphatase/guanylyltransferase) and RNMT (N-7
cap guanosine methyltransferase) are recruited to Ser-5 phos-
phorylated RNA pol II CTD (Ramanathan et al, 2016). We report that
CMTR1 also interacts directly with Ser-5 phosphorylated RNA pol II
CTD. DHX15 reduces CMTR1 methyltransferase activity in a dose-
dependent manner and DHX15–CMTR1 complexes are not recruited
to RNA pol II. Thus, the interaction of DHX15 with CMTR1 is likely to
constrain ﬁrst nucleotide O-2 methylation to the initial stages of
transcription, and restrain post-transcriptional, aberrantmethylation.
We demonstrate that CMTR1 interaction with DHX15 requires the
G-patch domain, whereas the CMTR1 interaction with RNA pol II CTD
requires the WW domain. The CMTR1-DHX15 complex may be unable
to be recruited to RNA pol II either because DHX15 changes the
conformation of CMTR1 or sterically hinders it frombinding to the CTD.
To our knowledge, CMTR1 is the only annotated G-patch–containing
protein with a catalytic domain and this is the ﬁrst example of
DHX15 regulating a catalytic activity. Interaction with DHX15 is required
for inhibition of CMTR1 methyltransferase activity; however, the
helicase/ATPase activity of DHX15 is not. The catalytic domain lies in
the centre of the CMTR1 polypeptide and the non-catalytic C- and
N-terminal domains inﬂuence methyltransferase activity (Smietanski
et al, 2014). Our data are consistent with DHX15 inducing a confor-
mational change in CMTR1 to reduce methyltransferase activity.
First nucleotide ribose O-2 methylation is associated with trans-
lational efﬁciency (Muthukrishnan et al, 1976a; Kuge & Richter, 1995;
Kuge et al, 1998). The impact of DHX15 on CMTR1-dependent trans-
lation was investigated using the CMTR1 2L/A mutant, which does not
bind to DHX15 but is recruited to RNA pol II. Expression of CMTR1 2L/A
resulted in increased ribosome loading of a subset of transcripts,
including those involved inmetabolic pathways and cell cycle control.
The genes sensitive to the DHX15–CMTR1 interaction may be partic-
ularly dependent on O-2methylation for polysome loading or require
high levels of CMTR1 activity to be O-2 methylated. Expression of
CMTR1 2L/A also resulted in increased cell proliferation.
CMTR1 inﬂuences DHX15 function
The mechanism by which G-patch proteins regulate the activity and
localisation of Prp43 (yeast DHX15 orthologue), are well charac-
terised. Prp43 uses the energy generated by ATP hydrolysis to power
helicase activity (Walbott et al, 2010). The Prp43 RecA domains
interact with the C-terminal domain, rendering the enzyme in
a closed conformation. Disruption of these interactions by ATP
binding promotes changes in the helicase structure, leading to the
open conformation required for unwinding complex RNA stretches
(Tauchert et al, 2017). In addition, the stacking of the adenosine
base with the RecA1 R and RecA2 F motifs is important for the
activity and regulation of the helicase (Robert-Paganin et al, 2017).
When intrinsically unstructured G-patch domains bind to the Prp43
OB-fold, they adopt a stable open secondary structure (Christian
et al, 2014). G-patch domains can inﬂuence both the stacking of the
adenosine base and interactions of N- and C-terminal domains,
thus regulating Prp43 catalytic activity (Robert-Paganin et al, 2017;
Tauchert et al, 2017).
We observe that CMTR1 activates DHX15 helicase activity. Similar to
several other G-patch proteins, CMTR1 activates helicase activity
without regulating ATPase activity (Memet et al, 2017). A similar ob-
servationwasmadewith the yeast splicing factor Ntr1, which does not
alter Prp43 ATPase activity but does activate the helicase (Tanaka
et al, 2007). Furthermore, there are now several examples of G-patch
proteins impacting differentially on Prp43 activity and function
(Aravind & Koonin, 1999; Banerjee et al, 2015; Tauchert et al, 2017).
The competition of cofactors for Prp43 was previously observed to
regulate its distribution between different pathways (Heininger et al,
2016). Consistent with a previous publication, we observed DHX15 co-
localising with a splicing factor, SC35, in nuclear speckles (Tannukit
et al, 2009). Suppression of CMTR1 expression resulted in an increased
number of cells with DHX15 in nuclear speckles. CMTR1 may compete
with other G-patch proteins for DHX15 binding and/or the impact that
CMTR1 has on the cell cycle may indirectly inﬂuence the number of
nuclear speckles. The indirect impact of CMTR1 suppression can be
observed by a change in nuclear morphology from spheroid to lobed
(Fig 6), and by an impact on cell proliferation (Fig 8).
The co-ordinated impact of DHX15 and CMTR1 on gene expression
Ultimately, we want to understand how the relationship between
DHX15 and CMTR1 impacts on cell function. This is complex because
of the multifunctional nature of both enzymes. The impact of the
DHX15–CMTR1 interaction will depend on the relative expression of
the enzymes and their other interacting partners, which also inﬂu-
ence enzyme activity and localisation. The impact of the DHX15–
CMTR1 interaction will also depend on the underlying cell physiology,
including relative dependency on O-2 methylation, splicing, rRNA
processing, and translation. Of note, CMTR1 is an interferon-regulated
gene, whereas DHX15 is not, and therefore, interferon signalling alters
the ratio of these factors. In this study, we focus on the biological
impact of DHX15 repression of CMTR1 methyltransferase activity and
function. We stress that, in certain contexts, the impact of CMTR1
activation of DHX15 helicase activity may be equivalently or more
biologically important, given the role of DHX15 in RNA processing.
In summary, we now recognise that the mRNA capping enzymes,
RNGTT, RNMT, and CMTR1 are regulated by different co-factors and
posttranslational modiﬁcations, with multiple impacts on gene
expression and cell physiology. The challenge now is to understand
the complex integration of these regulatory events during devel-
opment and in the adult.
Materials and Methods
Cell culture
HeLa, HEK293, MCF7, and U2OS cells were cultured in DMEM and
HCC1806 cells were cultured in Roswell Park Memorial Institute 1640
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medium. All cells were cultured with 10% (vol/vol) FBS, 100 U/ml
penicillin, 0.1 mg/ml streptomycin, and 2 mM L-glutamine. For
plasmid transfection, cells in 10-cm dishes were transfected with
1–5 μg plasmid using 20 μg polyethylenimine (Polysciences). Cells
were cultured for 36 h before lysis in 0.45 ml ice-cold lysis buffer
(50 mM Tris–HCl, pH 7.5, 1 mM EGTA, 1 mM EDTA, 1 mM sodium
orthovanadate, 10 mM β-glycerophosphate, 50 mM NaF, 5 mM
sodium pyrophosphate, and 0.27 M sucrose) supplemented with 1%
(vol/vol) Triton X-100, 2 mM DTT, 1% (vol/vol) aprotonin, 10 μM
leupeptin, and 1 μM pepstatin. Extracts were centrifuged at 16,200 g
at 4°C for 15 min and supernatant retained. For siRNA transfections,
cells were transfected with 50 nM siRNA (Dharmacon siGenome
range; non-targeting or CMTR1), for 48 h unless stated otherwise.
UAGAUGAUGUUCGGGAUUA, 01 CMTR1 siRNA; GUAAGAGCGUGUUU-
GAUGU, 02 CMTR1 siRNA. For plasmid and siRNA co-transfection,
lipofectamine 2000 (Thermo Fisher Scientiﬁc) was used. 2–6 × 104
cells were plated in a six-well plate, 0.5 μg pcDNA5 GFP, and 0.5 μg
pcDNA5 HA-CMTR1 WT or 2L/Amixed with siRNA before transfection.
Countess cell counter was used for cell counting.
Generation of a CMTR1 knockout cell line (CMTR1 del) using
CRISPR/Cas9
CMTR1 gene (ensembl ENSG00000137200) optimal scoring guide
target site GGGAGGTTCATCATCGGACG[TGG] was cloned into pBabeD
pU6 and sequence-veriﬁed (http://crispr.mit.edu/). HeLa cells
stably expressing Tet-regulated Cas9 were transfected with 3 μg
pBabeD pU6 CMTR1 using Lipofectamine 2000. Cells were incubated
in DMEM, 10% FBS, 2 mM L-glutamine, and 100 μg/ml Normocin
(InvivoGene). After 12 h, 4 μg/ml puromycin was added in fresh
medium. After 48-h selection, 2 μg/ml doxycycline was added to
induce Cas9 expression. After 72 h, single cells were FACS-sorted
into a 96-well plate containing DMEM/20% FBS, 2 mM L-glutamine,
100 U/ml penicillin, 100 μg/ml streptomycin, and 100 μg/ml Nor-
mocin (InvivoGene). CMTR1 protein expression was screened using
Western blot in 40 clones. For clones displaying an absence of
protein, genomic DNA was isolated and ampliﬁed by PCR, using
CMTR1 genomic forward: CTGTGATCCCAGTGGCTGT and CMTR1 ge-
nomic reverse: CCAAGGGGCAGTGGACTAT primers. PCR products
from control and CMTR1 del clones were sequenced. CMTR1 del
clone 5 had no region homology to WT cells around Cas9 targeting
sequence and selected for experiments.
IP and Western blot
For IP of GFP or HA-tagged proteins, anti–GFP antibody–conjugated
agarose (ChromoTek) and anti-HA antibody–conjugated agarose
(Sigma) were used. For endogenous proteins, 1 μg relevant antibody
was pre-incubated with 10 μl protein-G Sepharose packed beads
and washed to remove non-bound antibody. 0.5–2.5 mg lysates
were precleared with 10–30 μl protein-G Sepharose (GE Healthcare),
and then incubated with an antibody–resin conjugate for 2 h at 4°C
under gentle agitation. IPs were washed three times with lysis
buffer containing 0.1 M NaCl. Typically, 1%–2% input and 30% of IP
eluates were loaded for Western blot, except in Figs 1F and 4A–C in
which 15% of eluate was loaded. For RNAse treatment, 40 μg RNAse
A was incubated with IP or 2 μg HeLa RNA for 60 min at 4°C. Proteins
were eluted in SDS-sample buffer. Western blots were performed by
standard protocols. CMTR1 antibody was raised in sheep by Orygen
Antibodies Limited, UK and afﬁnity puriﬁed against the human
recombinant protein. Second bleed was used at 1 μg/ml for
Western blotting and the ﬁrst bleed was used at 1 μg/IP. Other
antibodies: RNGTT (in-house), HA (Sigma), DHX15 (ab70454; Abcam),
GAPDH (Cell Signaling Technologies), RNA pol II (N20; Santa Cruz),
PSer5-PolII (3E8; ChromoTek), and pSer2-PolII (3E10; ChromoTek).
Secondary antibodies were from Pierce.
Mass spectrometry analysis
IPs were resolved using SDS–PAGE and stained with Novex Colloidal
Blue (Invitrogen). Bands were excised and washed sequentially on
a vibrating platform with 0.5 ml water, 1:1 (vol/vol) water and
acetonitrile (AcN), 0.1 M ammonium bicarbonate, and 1:1 (vol/vol)
0.1 M ammonium bicarbonate and AcN. Samples were reduced
in 10 mM dithiothreitol (20 min, 37°C), alkylated in 50 mM iodoa-
cetamide/0.1 M ammonium bicarbonate (20 min, dark), and
washed in 50 mM ammonium bicarbonate and 50 mM ammonium
bicarbonate/50% AcN. When gel pieces were colourless they were
washed with AcN for 15 min and dried. Gel pieces were incubated
(16 h, 30°C) in 5 μg/ml trypsin/25 mM triethylammonium bicarbon-
ate. Tryptic digests were analysed by liquid chromatography–mass
spectrometry on an Applied Biosystems 4000 QTRAP system with
precursor ion scanning. The resulting MS/MS data were analysed by
Mascot search algorithm (http://www.matrixscience.com).
Bacterial expression and puriﬁcation of DHX15 and CMTR1
proteins
Bacterial expression plasmids pET15b-His6-DHX15 WT or E261Q and
pGEX6P1-GST-3C-CMTR1 WT or ΔG (residues 143–835) were trans-
formed into Rosetta 2 (DE3) cells (Novagen) and plated on LB agar/
100 μg/ml ampicillin and 35 μg/ml chloramphenicol. Starter cul-
tures were incubated at 37°C overnight. After 16 h, cultures were
diluted 1/50 into fresh 6-9L LB cultures and incubated at 37°C with
agitation. At OD600 ~ 0.3–0.4, the temperature was reduced to 16°C
and at OD600 ~ 0.7–0.8 protein expression was induced with 50 μM
Isopropyl β-D-1-thiogalactopyranoside for 14–16 h. Cultures were
harvested by centrifugation and pellets resuspended in ice-cold re-
suspension buffer (Tris 50 mM, pH 8, 200 mM NaCl, 1 mM DTT, 25 mM
imidazole, 10% glycerol [vol/vol], and Complete-EDTA free protease
inhibitor purchased from Roche). Resuspended cells were ﬂash-
frozen in liquid nitrogen, thawed in a lukewarm (25°C) water bath,
and treated with lysozyme (1 mg/ml) and DNase I (1:10,000 dilution)
for 30 min at 4°C. Cell debris and insoluble material were clariﬁed
by centrifugation at 38,000 relative centrifugal force at 4°C for
45 min. Soluble lysates were passed through poly-prep columns
packed with either Ni-NTA agarose (His6-DHX15) or GSH-sepharose
(GST-3C-CMTR1) pre-equilibrated in wash buffer (50 mM Tris, pH 8,
500mMNaCl, 1 mM DTT, 25 mM imidazole, and 5% glycerol [vol/vol]).
After binding, resins were extensively washed with wash buffer
followed by a ﬁnal wash step in low-salt (200 mMNaCl) wash buffer.
For His6-DHX15, Ni-NTA bound material was eluted with an elution
buffer (50 mM Tris, pH 8, 200 mM NaCl, 1 mM DTT, 5% glycerol, and
300 mM imidazole), whereas GSH-sepharose–bound GST-CMTR1
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was treated with GST-3C protease overnight at 4°C to cleave GST
tag. Eluted His6-DHX15 and CMTR1 proteins were concentrated
using an Amicon 30 kD- molecular weight cut off concentrator and
subjected to size-exclusion chromatography (Superdex 200) in
50 mM Tris, pH 8, 200 mM NaCl, 1 mM DTT, and 5% glycerol (vol/vol)
buffer on an AKTA puriﬁer FPLC system (Amersham). Proteins were
further concentrated and ﬂash-frozen as single use aliquots,
stored at −80°C.
Gel ﬁltration
0.5 ml of 2 mg/ml cell extract was 0.22-μm ﬁltered and resolved on
Superdex 200 10/300 GL preparative grade column (GE Healthcare)
in 50 mM Tris–HCl, pH 7.4, 1 mM EDTA, 0.1 M sodium chloride, 0.03%
Brij-35, and 2 mM DTT at 0.4 ml/min ﬂow. 0.5 ml fractions were
collected. Molecular weight markers (Bio-Rad) were used: bovine
thyroglobulin (670 kD), bovine gamma globulin (158 kD), and chicken
ovalbumin (44 kD).
First nucleotide O-2 methylation assay
A guanosine-capped substrate 32P-labelled on α-phosphate
(GpppG-RNA) was produced. 200 ng 55-base in vitro–transcribed
RNA was incubated with 100 ng RNA guanylyltransferase and
59-phosphatase (RNGTT), 2 μl (10 μCi) [α32P]GTP, and 1 μl RNAsin
(Promega) in 10 μl reaction buffer (0.05 M Tris–HCl, pH 8.0, 6 mM KCl,
and 1.25 mM MgCl2) at 37°C for 60 min. When used, a guanosine-
capped transcript was incubated with 100 ng RNMT and 0.2 μM SAM
for 20 min at 30°C to produce N-7 methylated guanosine cap
(m7GpppG-RNA). RNA was puriﬁed by ammonium acetate pre-
cipitation. Methyltransferase assay performed in 10 μl reaction
buffer, with 3 nM CMTR1 (or indicated nM), 2 ng 32P-labeled GpppG-
RNA or m7GpppG-RNA, and 10 μM SAM at 30°C for 30 min (unless
otherwise stated). Following the reaction, RNA was precipitated and
resuspended in 4 μl 50-mM sodium acetate and 0.25 U P1 nuclease
for 30min at 37°C. Cap structures were resolved in 0.4 M ammonium
sulphate on polyethyleneimine–cellulose plates, and visualized
and quantiﬁed by autoradiography. In Fig 3E, when cell extracts
were used in the assay, cells were lysed in a lysis buffer (as above)
and 5 μg cell extract was used in the methyltransferase reaction.
Molecular biology
cDNA cloning and mutagenesis were performed by standard pro-
tocols. Constructs were sequence-veriﬁed.
CTD peptide afﬁnity chromatography
RNA pol II CTD peptide chromatography was performed as in Ho &
Shuman (1999). 0.5 nmol biotinylated CTD peptides were absorbed
on 0.2 mg Streptavidin Dynabeads M-280 (Invitrogen) in 300 μl
binding buffer (25 mM Tris–HCl, pH 8, 50 mM NaCl, 1 mM DTT, 5%
Glycerol, and 0.03% Triton X-100). After 45 min at 4°C, beads were
magnet-concentrated and washed in binding buffer. 0.2 μg in-
dicated protein was mixed with peptide-beads in 50 μl binding
buffer. After incubation for 45 min at 4°C, beads were washed three
times with a binding buffer and bound fraction eluted with 30 μl
SDS–PAGE loading buffer at 95°C for 5 min.
ATPase activity assay
ATPase reactions performed as in Lebaron et al (2009). 100 nM His6-
DHX15, 0.6 μCi/μl [α32P] ATP, and 100–200 μM ATP were incubated in
5 μl buffer (25 mM Tris–acetate, pH 8.0, 2.5 mM Mg(CH3-COO)2,
100 mM KCl, 0.2 mM DTT, 100 μg/ml BSA [Sigma]) at 30°C for the time
indicated. 1 μl reaction mix was resolved on polyethyleneimin–
cellulose plates using 0.75 M KH2PO4. Spots were visualised and
quantiﬁed on a phosphorimager. When indicated, 1 μg HeLa cell
RNA was added to the reaction.
Cap-binding assays
Cap-binding assays were performed as in Rio (2014) with minor
modiﬁcations. Reactions were performed with 32P-labeled GpppG-
RNA as in O-2 methylation assays with indicated amount of en-
zymes. After 20 min incubation, reactions were stopped with 5 μl of
loading buffer (10 mM Tris, pH 7.5, 60 mM KCl, 5% glycerol, 0.01%
xylene cyanol, and bromophenol blue), loaded, and resolved in
4%–12% tris borate EDTA buffer non-denaturing acrylamide gel
(Invitrogen) for 75 min at constant 50 V and 4°C. Gel were ﬁxed (10%
acetic acid and 10%methanol) for 5 min, washed in 10% glycerol for
10 min, and detected using a phosphorimager.
Unwinding assay
Unwinding assay was performed as in Tanaka et al (2007). The
126-nucleotide (nt) RNA strand (59-GGGCGAAUUGGGCCCGACGUCGC-
AUGCUCCCGGCCGCCAUGGCGGCCGCGGGAAUUCGAUUAUCACUAGU-
GAAUUCGCGGCCGCCUGCAGGUCGACCAUAUGGGAGAGCUCCCAACGC-
GUUGGAUG-39) was synthesized by in vitro transcription, and annealed
at a 1:3 M ratio to 59 32P-labelled DNA (59-GACGTCGGGCCCAATTCGCCC-39)
to yield 59-tailed 30-bp duplex. The annealed substrate was gel-
puriﬁed on native 6% PAGE. 10 μl reaction mixtures containing
indicated concentrations of His6-DHX15 and CMTR1, and 2.5 nM
RNA/DNA substrate were incubated in 40 mM Tris–HCl, pH 7.0, 2 mM
DTT, and 1 mM ATP-Mg2+ at 37°C for 45 min. Reactions were halted
by transfer to ice and addition of 5 μl loading buffer (100 mM
Tris–HCl, pH 7.4, 5 mM EDTA, 0.5% SDS, 50% glycerol, 0.1% [wt/vol]
bromophenol blue, and xylene cyanol dyes). Samples were re-
solved on 16% polyacrylamide gel in 40 mM Tris–borate, 0.5 mM
EDTA, and 0.1% SDS. 32P-labeled substrate and products were vi-
sualized by autoradiography.
Immunoﬂuorescence
Immunoﬂuorescence was performed in 2% BSA/PBS at room
temperature. Cells were ﬁxed in 4% paraformaldehyde for 10
min, permeabilized with 1% NP-40/PBS for 3 min, blocked with
10% donkey serum for 20 min, and incubated in 1.4 μg/ml
polyclonal sheep anti-CMTR1 or DHX15 antibodies for 1.5 h,
washed, and incubated with 1.4 μg/ml Alexa Fluor 594– or
488–conjugated donkey anti-sheep or rabbit antibodies for
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45 min. Cells were counterstained with 1 μg/ml DAPI, mounted in
2.5% 1, 4-diazobicyclo-(2,2,2-octane), and visualized by ﬂuo-
rescence microscopy (LSM 700; Zeiss).
Polysome proﬁle
Cells were incubated in 100 μg/ml cycloheximide for 10 min and
washed in ice-cold PBS supplemented with 100 μg/ml cyclohexi-
mide, and extracts were collected in polysome lysis buffer (15 mM
Tris, pH 7.5, 15 mM MgCl2, 0.3 M NaCl, 1 mM DTT, 1% Triton X-100, 100
mg/ml cycloheximide, and 100 U/ml RNasin). 10% extracts were
retained as input and 90% resolved by centrifugation through 10 ml
10%–50% sucrose gradient at 18,000 g for 2 h at 4°C. Fractions were
collected on a FoxyR1 fractionator (Teledyne ISCO) with OD259 nm
monitoring.
RNA-sequencing and analysis
Extraction of polysomal RNA was performed as described pre-
viously (Grasso et al, 2016). Brieﬂy, polysomal fractions 16–20 were
puriﬁed using Phenol:Chloroform:Isoamyl alcohol (25:24:1). RNA was
precipitated overnight with 2 M of LiCl, 20 mM Tris, pH 7.5, and EDTA
10 mM. Input RNA was puriﬁed using Trizol Reagent. RNA was se-
quenced at the Tayside Centre for Genomic Analysis. RNA was
quality checked using TapeStation (Agilent Technologies). RNAseq
libraries were prepared with TruSeq Stranded Total RNA with Ribo-
Zero-Gold kit (Illumina). Sequencing was performed using NextSeq
Series High Output kit 2 × 75 bp (Illumina). Reads were quality
controlled using FastQC, then mapped to (GRCh38/hg25) assembly
of human genome and reads per gene quantiﬁed using STAR 2.5.2b
(Dobin et al, 2013). Differentially expressed genes were identiﬁed
using edgeR package (Robinson et al, 2010). Genes with at least 1
count per million in all samples were analysed for differential
expression. Pairwise comparisons were made between input RNA
and between polysomal RNA for samples transfected with pcDNA5,
pcDNA 5 HA-CMTR1 WT or 2L/A. Plots comparing differential input or
polysome mRNA abundance were drawn using the ggplot2 R
package.
RT–PCR
RNA was extracted using Trizol Reagent (Invitrogen). cDNA was
synthesised using iScript cDNA Synthesis Kit (Bio-Rad). RT–PCR was
performed using Quanta Biosciences SYBR Green. Primers:
PRKDC_Fwd GAGAAGGCGGCTTACCTGAG, PRKDC_Rvr CGAAGGCCCGC-
TTTAAGAGA, IGF2R_Fwd AGCGAGAGCCAAGTGAACTC, IGF2R_Rvr TCG-
CTGTAAGCAGCTGTGAA, CAD_Fwd AGGTTTGCCAGCTGAGGAG, CAD_Rvr
TAATGAGTGCAGCAGGGGTG, ATR_Fwd GGAGGAGTTTTGGCCTCCAC, A-
TR_Rvr TGTGGCACTGCCCAGCTC, GCN1_Fwd CTTGTGCCCAAGCTGACAAC,
GCN1_Rvr GCCCTGTGTCATCCTCTACG, MTOR_FwdGAAGCCGCGCGAACCT,
MTOR_Rvr CTGGTTTCCTCATTCCGGCT, CMTR1_Fwd CATTGCCCCATTTCA-
CATTTGC, CMTR1_Rvr TCTTAGGCCCTGTGCATCTG.
RNAseq data
RNAseq data can be found in the GEO database record GSE113573.
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
201800092.
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